Return to Listing

1 result(s) for MK-3475

PI Name Protocol # Title
Jacqueline Vuky IRB00011260 A Phase II Clinical Trial of Pembrolizumab (MK-3475) in Subjects with Advanced/Unresectable or Metastatic Urothelial Cancer
 

You may also qualify for Phase 1 Program trials.

 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080